Request Deal Involvement

VERAXA Biotech to go public via a SPAC merger with Voyager Acquisition in a $1.64bn deal.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Anne Martina Group

financial advisors

Anne Martina Group

Valency Communications

pr advisors

Valency Communications

Duane Morris

legal advisors

Duane Morris

FTI Consulting

pr advisors

FTI Consulting

Winston & Strawn

legal advisors

Winston & Strawn

or

Principals

VERAXA BIOTECH

target

VERAXA BIOTECH

VOYAGER ACQUISITION CORP

bidder

VOYAGER ACQUISITION CORP

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - VERAXA Biotech to go public via a SPAC merger with Voyager Acquisition in a $1.64bn deal.